Genomic Science and Health Equity Postdoctoral Fellowship
NIH, NHGRI and FDA, OMHHE
Location: Bethesda, Maryland
Required Education: Doctorate
Academic / Research
Internal Number: n/a
Elevating equity of voice for diverse patients with hereditary rare diseases
A postdoctoral fellowship in genomic science and health equity, cosponsored by the National Institutes of Health’s (NIH) National Human Genome Research Institute (NHGRI) and the Food and Drug Administration’s (FDA) Office of Minority Health and Health Equity (OMHHE), is open for applications.
The fellowship program is designed to prepare fellows to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity and train them in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics and devices from bench to bedside.
The fellow will gain unique experiences by working closely with mentors at both FDA and NIH, including the opportunity to advance their knowledge of health disparity and regulatory sciences.
More than 30 million Americans — nearly 1 in 10 — have a rare disease. And there is a disproportionate burden for racial and ethnic minority patients who have a hereditary rare disease. Fellows who are interested in mixed methods studies at the intersection of health equity and rare disease research are encouraged to apply.
The fellow selected for this position will pursue research broadly related to:
Leveraging qualitative and quantitative methodology to understand and elevate the voices of diverse patients living with hereditary rare diseases.
Incorporating the diverse family, caregiver and patient perspective to increase comprehensive understanding of the patient’s journey.
Increasing the understanding of barriers to clinical trials, including economic factors, for diverse patients who have a hereditary rare disease.
Integrating diverse family, patient and caregiver voices, perspectives and unmet needs into regulatory decision making.
Have or obtain a Ph.D., M.D., Pharm.D. or D.V.M. in medicine, human genetics, genomics, computational biology, cell or molecular biology, epidemiology, biostatistics, public health, social and behavioral science, or closely related areas.
Have fewer than five years of relevant research experience since receipt of most recent doctoral degree.
Have some knowledge of statistics and qualitative research methods, excellent communication skills and fluency in both spoken and written English.
Be a U.S. citizen or a permanent resident.
How to Apply:
Applications are currently being accepted and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2022. For questions about the fellowship program please contact Jamil B. Scott, Ph.D., M.P.H., at NHGRIFDAFellowship@nih.gov or Christine Lee, Pharm.D., Ph.D., at ChristineS.Lee@fda.hhs.gov.
The National Human Genome Research Institute (NHGRI) was established originally as the National Center for Human Genome Research in 1989 to lead the International Human Genome Project. NHGRI is part of the National Institutes of Health (NIH), the nation’s medical research agency. NHGRI funds and conducts research to uncover the role that the genome plays in human health and disease. This research occurs across a spectrum: basic research to shed light on the structure and function of the genome; translational research to decipher the molecular bases of human diseases; and clinical research to establish how to use genomic information to advance medical care. NHGRI also supports exploration of the complex ethical, legal, and social implications of genomics, and is committed to ensuring that the knowledge and benefits generated from genomics research are disseminated widely, both to fuel current and future researchers and to benefit the general public and promote genomic literacy.
The Food and Drug Administration (FDA) is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping th...e public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. The FDA Office of Minority Health and Health Equity (OMHHE) serves to promote and protect the health of diverse populations through research and communication of science that addresses health disparities. The FDA OMHHE aims to: (1) increase the amount of clinical trial data available on racial and ethnic minorities; improve the data quality to determine how minorities react to medical products; and increase transparency and access to available data; (2) strengthen FDA’s ability to respond to minority health concerns and (3) promote health and safety communication to minority populations who often experience low health literacy and/or speak English as a second language.